Clinical Trials Browser

Phase 2 × Interventional × SHR-1210 × Clear all

NCT04797507 2021-03-15

SHR-1210 in Combination With Anlotinib in Patients With Advanced or Metastatic Esophageal Squamous Cell Cancer

Phase 2 Unknown

Gastrointestinal

SHR-1210